You are here: Welcome » Chiachen Cheng

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
chiachen_cheng [2022/05/02 05:53]
liam 		chiachen_cheng [2022/05/02 06:17] (current)
liam [Awards and funding]
Line 15: Line 15:
 ===== Career and Affiliations ===== ===== Career and Affiliations =====
  
 +==== Ontario Psychiatric Association ====
 +
 +Cheng was a member of the executive council of the [[Ontario Psychiatric Association]] in 2005.((//Dialogue.// (2005, June). Ontario Psychiatric Association. https://web.archive.org/web/20220502040248/https://www.eopa.ca/sites/default/uploads/files/DialogueNL_June2005.pdf)) ((//Dialogue.// (2005, March). Ontario Psychiatric Association. https://web.archive.org/web/20220502040455/https://www.eopa.ca/sites/default/uploads/files/DialogueNL_Mar2005.pdf))
 +
 +At the time, sponsors for the OPA included [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Biovail]], [[pharmaceutical_companies:Eli Lilly]], [[pharmaceutical_companies:Genpharm]], [[pharmaceutical_companies:Lundbeckl]], [[pharmaceutical_companies:Organon]], [[pharmaceutical_companies:Shire]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], and [[pharmaceutical_companies:Wyeth]] (a [[pharmaceutical_companies:Pfizer]] company).
 ==== Northern Ontario School of Medicine ==== ==== Northern Ontario School of Medicine ====
  
Line 33: Line 38:
 ==== SickKids Foundation ==== ==== SickKids Foundation ====
  
-In 2017, Cheng served as a member of the New Investigator Program Grant Review Committee for the [[SickKids Foundation.((//New Investigator Program Grant Review Committee September 2017.// (2017, September). Wayback Machine; SickKids Foundation. https://web.archive.org/web/20220502035214/https://www.sickkidsfoundation.com/-/media/files/skf/downloadable-resources/pdfs/about-us/grants/grc-members-list-2017.pdf))+In 2017, Cheng served as a member of the New Investigator Program Grant Review Committee for the [[SickKids Foundation]].((//New Investigator Program Grant Review Committee September 2017.// (2017, September). Wayback Machine; SickKids Foundation. https://web.archive.org/web/20220502035214/https://www.sickkidsfoundation.com/-/media/files/skf/downloadable-resources/pdfs/about-us/grants/grc-members-list-2017.pdf))
  
 ==== Ontario COVID-19 Science Advisory Table ==== ==== Ontario COVID-19 Science Advisory Table ====
Line 44: Line 49:
  
 In February 2020, Cheng received the PSI-50 Mid-Career Clinical Research Award from the [[PSI Foundation]].((//PSI-50 Mid-Career Clinical Research Award - Dr. Chiachen Cheng.// (2020, February 18). PSI Foundation. https://www.psifoundation.org/psi-50-mid-career-clinical-research-award-dr-chiachen-cheng/)) In February 2020, Cheng received the PSI-50 Mid-Career Clinical Research Award from the [[PSI Foundation]].((//PSI-50 Mid-Career Clinical Research Award - Dr. Chiachen Cheng.// (2020, February 18). PSI Foundation. https://www.psifoundation.org/psi-50-mid-career-clinical-research-award-dr-chiachen-cheng/))
 +
 +Cheng has co-authored research funded by the [[Canadian Pharmaceutical Association]] (CPhA, now the [[Canadian Pharmacists Association]]) and the [[Canadian Medical Association]] (CMA).((//Meta-analysis of benzodiazepine use in the treatment of insomnia.//
 +Anne M. Holbrook, Renée Crowther, Ann Lotter, Chiachen Cheng, Derek King
 +CMAJ Jan 2000, 162 (2) 225-233))
Back to top